[PHAS] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[PHAS] PhaseBio Pharmaceuticals, Inc.
Announcement Date
12-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 10.66%
YoY- -120.73%
Quarter Report
PHAS's Result
PHAS's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 10,338 0 0 241 703 320 764 468.74%
PBT -27,079 -27,358 -30,375 -25,143 -28,142 -14,905 -11,331 78.84%
Tax 1,600 -1,426 -4,071 -4,289 -3,665 -239 314 196.40%
NP -28,679 -27,358 -30,375 -25,143 -28,142 -14,905 -11,331 85.82%
Tax Rate - - - - - - - -
Total Cost 39,017 27,358 30,375 25,384 28,845 15,225 12,095 118.47%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -277.41 0.00 -9,492,187,500,000,000.00 -10,432.78 -4,003.13 -4,657.81 -1,483.12 -67.32%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.60 -0.87 -1.03 -0.86 -0.98 -0.52 -0.39 33.30%
EPS Diluted -0.60 -0.87 -1.03 -0.86 -0.98 -0.52 -0.39 33.30%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.